The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study. MK-4482, delivered orally, is now in human clinical trials.
source https://www.sciencedaily.com/releases/2021/04/210416120127.htm
Saturday, 17 April 2021
Previous Post
On the pulse of pulsars and polar light
Related Posts
Research finds college students with ADHD are likely to experience significant challenges
Some open ocean waters teeming with an abundance of life
TBE patients' lasting problems
New material is next step toward stable high-voltage long-life solid-state batteries
Drifter or homebody? Study first to show where whitespotted eagle rays roam
Seasonal variation in daylight influences brain function
0 comments: